Yoav Amitai – CEO – Elsight's (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.
Copyright 2023 – Finance News Network
Source: Finance News Network
20 Dec 2023 - Explore the latest developments with BluGlass CEO Jim Haden as he delves into the company's significant defense contract win and the strategic acquisition of GaNWorks. Discover how these milestones drive BluGlass' position at the forefront of quantum laser innovation in 2024, unlocking new potentials in defense, quantum computing, and beyond.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More21 Aug 2020 - DigitalX Limited (ASX:DCC) Executive Director Leigh Travers provides an update on the company's strategy, its focus on blockchain consulting and development for the enterprise market and digital asset management, the impact of COVID-19, and priorities.
Read More16 Aug 2023 - Mark Leong - Executive Chairman - Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Read More05 Aug 2024 - BlinkLab Limited (ASX:BB1) Non-Executive Chairman Brian Leedman discusses transforming smartphones into diagnostic tools.
Read More06 Apr 2020 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its new drug application with the US FDA for Technegas and applications beyond pulmonary embolism in chronic chronic obstructive pulmonary ( COPD ) and asthma.
Read More27 May 2024 - Jonathan Belz, founder of BFA Global connects Australian and Asian family offices with top global investment opportunities in venture capital, private equity, and technology. He shares insights into the future of alternative assets and investment strategies.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More29 Mar 2021 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt talks about the Bristol Myers Squibb trial evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in patients with previously untreated metastatic or unresectable melanoma, meeting its primary endpoint of progression-free survival and what it means for Immutep.
Read More23 May 2023 - Flynn Gold Limited (ASX:FG1) Managing Director Neil Marston discusses the company's portfolio of projects, focusing on the company's gold exploration in north-east Tasmania.
Read More
